NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

PCR 市場預測(2021-2025 年):定量 PCR、數位 PCR、單重和多路使用/產品/冠狀病毒病 (COVID-19) 的位置影響

PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. Updated to include impact of Covid-19 Dx. 2021 to 2025

出版商 Howe Sound Research 商品編碼 1005157
出版日期 內容資訊 英文 415 Pages
商品交期: 最快1-2個工作天內
價格
PCR 市場預測(2021-2025 年):定量 PCR、數位 PCR、單重和多路使用/產品/冠狀病毒病 (COVID-19) 的位置影響 PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. Updated to include impact of Covid-19 Dx. 2021 to 2025
出版日期: 2021年05月12日內容資訊: 英文 415 Pages
簡介

PCR技術已經出現,因為它被用於診斷新型冠狀病毒感染(COVID-19),加速了基於PCR的新技術的發展。由於對新型冠狀病毒感染 (COVID-19) 診斷的巨大需求,預計增長將進一步加速。高靈敏度 PCR 技術還應用於液體活檢和癌症檢測。

本報告調查了 PCR 檢測市場,提供了市場和技術概述、行業趨勢、市場規模趨勢和預測、市場增長和製約因素分析、PCR 市場的近期趨勢、應用、技術、產品和產品。按地點匯總了主要公司的概況等。

目錄

第 1 章市場概覽

  • 情況分析
  • 高級營銷人員指南
  • 投資分析師和管理顧問指南

第 2 章市場的介紹和定義

  • 什麼是 PCR 技術?
  • PCR 和症候群檢測
  • 市場定義
  • 調查方法
    • 作者
    • 來源

第 3 章 PCR 技術

  • 概念
    • 方法
  • 應用
    • 查找特定的 DNA
    • DNA 測量
    • 醫療和診斷應用
  • 優點和缺點
  • PCR 類型

第 3 章行業概況

  • 參加機構
    • 學術研究所
    • 診斷測試開發公司
    • 基因組測量供應商
    • 醫藥/試劑供應商
    • 獨立檢驗實驗室
    • 公共研究所
    • 醫院實驗室
    • 博士實驗室
    • 審計機構
    • 認證機構

第 5 章市場趨勢

  • 生長促進因素
  • 生長抑制因素
  • 診斷技術的發展

第 6 章近期趨勢

  • Bio Molecular Systems:批准用於便攜式 PCR 循環儀
  • Roche:收購 GenMark
  • 手持式 qPCR 裝置接近商業化
  • Nuclein:融資 1400 萬美元
  • WuXi Diagnostics:結束 1.5 億美元 B 輪融資
  • Visby Medical:開發出快速的流感-COVID PCR 檢測
  • Thermo Fischer:收購 Mesa Biotech
  • Scope Fluidics:支持 Quick MDx 並賺取 620 萬歐元
  • 2022 年後仍將繼續需要 SARS 檢查
  • 瘧疾測試使用 CRISPR 在護理點檢測多種類型的生物
  • Fluidigm:SARS-CoV-2 使用 RT-PCR,無需提取唾液進行檢測
  • Visby Medical:淋病測試贏得 1900 萬美元的 AMR 診斷競賽
  • HelixBind:從 NIH 獲得 300 萬美元贈款,用於擴展傳染病診斷平台
  • Nucleix:瞄準美國市場進行膀胱癌和肺癌檢測
  • DxTerity:獲得家用樣品採集設備的 CE 標誌
  • dDigital PCR 演示了基於胎兒細胞的 NIPT
  • ChromaCode:通過新的高清 PCR 技術籌集了 2800 萬美元
  • ddPCR 用於快速、低成本的 NIPT 篩查
  • ChromaCode HDPCR (TM):一項驗證蜱傳病原體檢測的研究
  • Bio-Rad:出現 ddPCR MSI RUO 檢測
  • ctDNA 監測對於 BRAF 突變黑色素瘤很重要
  • Sysmex Inostics:液體活檢顯示雙倍檢出率
  • QIAGEN:規劃下一代數字 PCR 系統
  • Bioneer:韓國 FDA 批准的 HIV-1 Dx 試劑盒
  • PCR新技術-轉移PCR(tPCR)的應用
  • NimaGen:Salisbury NHS Foundation Trust 的許可 PCR 技術
  • Natera:將大規模多重 PCR 應用於腎移植
  • Paragon Genomics 和 MGI Tech:建立分銷合作夥伴關係

第 7 章主要公司簡介

  • Abacus Diagnostica
  • Abbott Diagnostics
  • Accelerate Diagnostics
  • Ador Diagnostics
  • Agilent
  • Akonni Biosystems
  • Alveo Technologies
  • Applied BioCode
  • Aus Diagnostics
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Binx Health
  • Biocartis
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Caris Molecular Diagnostics
  • Cepheid(now Danaher)
  • Credo Diagnostics Biomedical
  • Cue Health
  • Curetis N.V./Curetis GmbH
  • Diagenode Diagnostics
  • Diasorin S.p.A.
  • Enzo Life Sciences, Inc.
  • Eurofins Scientific
  • Fluidigm Corp
  • Fluxergy
  • Fusion Genomics
  • Genetic Signatures
  • GenMark Dx
  • Hibergene Diagnostics
  • Hologic
  • Immunexpress
  • Inflammatix
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexagene
  • LightDeck Diagnostics
  • Luminex Corp
  • Maxim Biomedical
  • Mbio Diagnostics
  • Meridian Bioscience
  • Mesa Biotech
  • Millipore Sigma
  • MIODx
  • Mobidiag
  • Nanomix
  • NGeneBio
  • Operon
  • Panagene
  • Perkin Elmer
  • Precipio
  • Primerdesign
  • Promega
  • Prominex
  • Qiagen Gmbh
  • Quantumdx
  • Quidel
  • Roche Molecular Diagnostics
  • Saw Diagnostics
  • Seegene
  • Siemens Healthineers
  • SkylineDx
  • Sona Nanotech
  • SpeeDx
  • T2 Biosystems
  • Thermo Fisher Scientific Inc
  • Veramarx
  • Visby Medical
  • XCR Diagnostics

第 8 章全球 PCR 市場

  • 市場概覽:按國家/地區
  • 市場趨勢:按應用
  • 市場趨勢:按技術
  • 市場趨勢:按產品分類
  • 市場趨勢:按地點

第 9 章全球 PCR 市場:按應用

  • 臨床多重測試
  • 臨床單重測試
  • 研究
  • 單C19
  • 其他

第 10 章全球 PCR 市場:按技術

  • 定量 PCR (qPCR)
  • 數位 PCR (dPCR)
  • 單一 C19 PCR

第 11 章全球 PCR 市場:按產品分類

  • 設備
  • 核酸提取
  • 消耗品
  • 服務

第 12 章全球 PCR 市場:按位置

  • 臨床實驗室
  • 護理點 (PoC)
  • 商業
  • 製藥
  • 其他

第 13 章附錄

目錄

OVERVIEW:

COVID-19 Diagnostics is driving PCR into a dominant technology role and spurring the growth of new PCR based technologies. Will thermal cycling become obsolete?

Are singleplex tests going to be obsolete? Will routine respiratory screening become a reality? Will diagnostics move into the Physician's Office or even the Home? Will digital PCR become the new lab standard?

Our facts and support = Your success.

The report forecasts the market size out to 2025 with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. Driven even faster by the huge demand for pandemic diagnostics. New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

  • 1.1 Situation Analysis
  • 1.2 Guide for Executives and Marketing Staff
  • 1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

  • 2.1 What are PCR Technologies?
  • 2.2 PCR and Syndromic Testing
  • 2.3 Market Definition
    • 2.3.1 Market Size
    • 2.3.2 Currency
    • 2.3.3 Years
  • 2.4 Methodology
    • 2.4.1 Authors
    • 2.4.2 Sources
  • 2.5 U.S. Medical Market and laboratory Testing - Perspective
    • 2.5.1 U.S. Medicare Expenditures for Laboratory Testing

3 PCR - Guide to PCR Technologies

  • 3.1 Concepts
    • 3.1.1 Method
  • 3.2 Applications
    • 3.2.1 Finding Specific DNA
    • 3.2.2 Measuring DNA
    • 3.2.3 Medical and diagnostic applications
      • 3.2.3.1 Carrier, prenatal and tissue typing
      • 3.2.3.2 Cancer Diagnosis and Management
      • 3.2.3.3 Infectious disease - New Levels of Accuracy and Sensitivity
      • 3.2.3.4 Forensic applications
      • 3.2.3.5 Science and Research
  • 3.3 PCR - Advantages and Disadvantages
  • 3.4 Different Types of PCR
    • 3.4.1 Simple Changes
      • 3.4.1.1 Multiplex-PCR
      • 3.4.1.2 VNTR PCR
      • 3.4.1.3 Asymmetric PCR
      • 3.4.1.4 Long PCR
      • 3.4.1.5 Nested PCR
      • 3.4.1.6 Quantitative PCR
      • 3.4.1.7 Hot-start PCR
      • 3.4.1.8 Touchdown PCR
      • 3.4.1.9 Assembly PCR
      • 3.4.1.10 Colony PCR
      • 3.4.1.11 Suicide PCR
      • 3.4.1.12 Cold PCR
    • 3.4.2 Digital PCR
      • 3.4.2.1 Droplet Digital PCR
      • 3.4.2.2 Comparison between dPCR and Real-Time PCR (qPCR)
      • 3.4.2.3 Digital PCR in Use
      • 3.4.2.4 Digital PCR Commercial History
    • 3.4.3 Isothermal PCR

4 Industry Overview

  • 4.1 Players in a Dynamic Market
    • 4.1.1 Academic Research Lab
    • 4.1.2 Diagnostic Test Developer
    • 4.1.3 Genomic Instrumentation Supplier
      • 4.1.3.1 Cell Separation and Viewing Instrumentation Supplier
    • 4.1.4 Pharmaceutical/Reagent Supplier
    • 4.1.5 Independent Testing Lab
    • 4.1.6 Public National/regional lab
    • 4.1.7 Hospital lab
    • 4.1.8 Physician Lab
    • 4.1.9 Audit Body
    • 4.1.10 Certification Body

5 Market Trends

  • 5.1 Factors Driving Growth
    • 5.1.1 A New Standard
    • 5.1.2 Down the Curve We Go
    • 5.1.3 Multiplexing
    • 5.1.4 Syndromic Diagnostics Looks Unstoppable
    • 5.1.5 The Genetic Blizzard
  • 5.2 Factors Limiting Growth
    • 5.2.1 The Cost Curve
    • 5.2.2 The Other Guys
    • 5.2.3 Systemic Roadblocks
  • 5.3 Diagnostic Technology Development
    • 5.3.1 The Instrumentation Curve
    • 5.3.2 Shifting Role of Diagnostics
    • 5.3.3 Diagnostics Moves Out of the Hospital
    • 5.3.4 Disruption Looms
    • 5.3.5 The Next Five Years

6 PCR Recent Developments

  • 6.1 Recent Developments - Importance and How to Use This Section
    • 6.1.1 Importance of These Developments
    • 6.1.2 How to Use This Section
  • 6.2 Bio Molecular Systems Gets Approval for Portable PCR Cycler
  • 6.3 Roche Acquires GenMark
  • 6.4 Handheld qPCR Devices Close to Commercialization
  • 6.5 Nuclein Closes $14M in Funding
  • 6.6 WuXi Diagnostics Closes $150M Series B Financing Round
  • 6.7 Visby Medical to develop rapid Flu-COVID PCR test
  • 6.8 Thermo Fisher to acquire Mesa Biotech
  • 6.9 Scope Fluidics Secures €6.2M Supporting Rapid MDx
  • 6.10 SARS- Testing Demand to Continue 'Through 2022, and Beyond'
  • 6.11 Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
  • 6.12 Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
  • 6.13 Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
  • 6.14 HelixBind Receives $3M NIH Grant to Expand Infection Dx Platform
  • 6.15 Nucleix Targeting US Market With Bladder, Lung Cancer Assays
  • 6.16 DxTerity Gets CE Mark for At-Home Sample Collection Device
  • 6.17 Fetal Cell-Based NIPT by dDigital PCR Demonstrated
  • 6.18 ChromaCode Raises $28M for new High Def PCR Technology
  • 6.19 ddPCR Used for Fast and Low-Cost NIPT Screening
  • 6.20 Study Validates ChromaCode HDPCR™ Testing for Tick-Borne Pathogens
  • 6.21 Bio-Rad's ddPCR MSI RUO Assay is available
  • 6.22 ctDNA Monitoring Is Important for BRAF-Mutant Melanoma
  • 6.23 Sysmex Inostics Liquid Biopsy Demonstrates Two-fold Higher Detection
  • 6.24 QIAGEN Plans for Next-Generation Digital PCR Systems
  • 6.25 Bioneer HIV-1 Dx Kit Gets Korea FDA Approval
  • 6.26 New PCR Technology: Transfer-PCR (tPCR) Applications
  • 6.27 NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust
  • 6.28 Natera Applies Massively Multiplexed PCR to Kidney Transplants
  • 6.29 Paragon Genomics, MGI Tech Form Distribution Alliance

7 Profiles of Key PCR Companies

  • 7.1 Abacus Diagnostica
  • 7.2 Abbott Diagnostics
  • 7.3 Accelerate Diagnostics
  • 7.4 Ador Diagnostics
  • 7.5 Agilent
  • 7.6 Akonni Biosystems
  • 7.7 Alveo Technologies
  • 7.8 Applied BioCode
  • 7.9 Aus Diagnostics
  • 7.10 Beckman Coulter Diagnostics
  • 7.11 Becton, Dickinson and Company
  • 7.12 Binx Health
  • 7.13 Biocartis
  • 7.14 bioMérieux Diagnostics
  • 7.15 Bioneer Corporation
  • 7.16 Bio-Rad Laboratories, Inc.
  • 7.17 Bosch Healthcare Solutions GmbH
  • 7.18 Bruker
  • 7.19 Caris Molecular Diagnostics
  • 7.20 Cepheid (now Danaher)
  • 7.21 Credo Diagnostics Biomedical
  • 7.22 Cue Health
  • 7.23 Curetis N.V. / Curetis GmbH
  • 7.24 Diagenode Diagnostics
  • 7.25 Diasorin S.p.A.
  • 7.26 Enzo Life Sciences, Inc.
  • 7.27 Eurofins Scientific
  • 7.28 Fluidigm Corp
  • 7.29 Fluxergy
  • 7.30 Fusion Genomics
  • 7.31 Genetic Signatures
  • 7.32 GenMark Dx
  • 7.33 Hibergene Diagnostics
  • 7.34 Hologic
  • 7.35 Immunexpress
  • 7.36 Inflammatix
  • 7.37 Invetech
  • 7.38 Janssen Diagnostics
  • 7.39 Karius
  • 7.40 Lexagene
  • 7.41 LightDeck Diagnostics
  • 7.42 Luminex Corp
  • 7.43 Maxim Biomedical
  • 7.44 Mbio Diagnostics
  • 7.45 Meridian Bioscience
  • 7.46 Mesa Biotech
  • 7.47 Millipore Sigma
  • 7.48 MIODx
  • 7.49 Mobidiag
  • 7.50 Nanomix
  • 7.51 NGeneBio
  • 7.52 Operon
  • 7.53 Panagene
  • 7.54 Perkin Elmer
  • 7.55 Precipio
  • 7.56 Primerdesign
  • 7.57 Promega
  • 7.58 Prominex
  • 7.59 Qiagen Gmbh
  • 7.60 Quantumdx
  • 7.61 Quidel
  • 7.62 Roche Molecular Diagnostics
  • 7.63 Saw Diagnostics
  • 7.64 Seegene
  • 7.65 Siemens Healthineers
  • 7.66 SkylineDx
  • 7.67 Sona Nanotech
  • 7.68 SpeeDx
  • 7.69 T2 Biosystems
  • 7.70 Thermo Fisher Scientific Inc
  • 7.71 Veramarx
  • 7.72 Visby Medical
  • 7.73 XCR Diagnostics

8 The Global PCR Markets

  • 8.1 PCR - Global Market Overview by Country
    • 8.1.1 Table - Global Market by Country
    • 8.1.2 Chart - Global Market by Country
  • 8.2 Global Market by Application - Overview
    • 8.2.1 Table - Global Market by Application
    • 8.2.2 Chart - Global Market by Application - Segments Growth
    • 8.2.3 Chart - Global Market by Application - Base/Final Comparison
    • 8.2.4 Chart - Global Market by Application - Base Year
    • 8.2.5 Chart - Global Market by Application - Final Year
    • 8.2.6 Chart - Global Market by Application - Share by Year
  • 8.3 Global Market by Technology - Overview
    • 8.3.1 Table - Global Market by Technology
    • 8.3.2 Chart - Global Market by Technology - Segments Growth
    • 8.3.3 Chart - Global Market by Technology - Base/Final Comparison
    • 8.3.4 Chart - Global Market by Technology - Base Year
    • 8.3.5 Chart - Global Market by Technology - Final Year
    • 8.3.6 Chart - Global Market by Technology - Share by Year
  • 8.4 Global Market by Product - Overview
    • 8.4.1 Table - Global Market by Product
    • 8.4.2 Chart - Global Market by Product - Segments Growth
    • 8.4.3 Chart - Global Market by Product - Base/Final Comparison
    • 8.4.4 Chart - Global Market by Product - Base Year
    • 8.4.5 Chart - Global Market by Product - Final Year
    • 8.4.6 Chart - Global Market by Product - Share by Year
  • 8.5 Global Market by Place - Overview
    • 8.5.1 Table - Global Market by Place
    • 8.5.2 Chart - Global Market by Place - Segments Growth
    • 8.5.3 Chart - Global Market by Place - Base/Final Comparison
    • 8.5.4 Chart - Global Market by Place - Base Year
    • 8.5.5 Chart - Global Market by Place - Final Year
    • 8.5.6 Chart - Global Market by Place - Share by Year

9 Global PCR Markets - By Application

  • 9.1 PCR Clinical Multiplex
    • 9.1.1 Table PCR Clinical Multiplex Testing - by Country
    • 9.1.2 Chart - PCR Clinical Multiplex Testing Growth
  • 9.2 PCR Clinical Singleplex
    • 9.2.1 Table PCR Clinical Singleplex Testing - by Country
    • 9.2.2 Chart - PCR Clinical Singleplex Testing Growth
  • 9.3 PCR Research
    • 9.3.1 8.4.1 Table PCR Research - by Country
    • 9.3.2 Chart - PCR Research Growth
  • 9.4 PCR Single C19
    • 9.4.1 Table PCR Single C19 - by Country
    • 9.4.2 Chart - PCR Single C19 Growth
  • 9.5 PCR Other
    • 9.5.1 Table PCR Other - by Country
    • 9.5.2 Chart - PCR Other Growth

10 Global PCR Markets - By Technology

  • 10.1 qPCR
    • 10.1.1 Table qPCR - by Country
    • 10.1.2 Chart - qPCR Growth
  • 10.2 dPCR
    • 10.2.1 Table dPCR - by Country
    • 10.2.2 Chart - dPCR Growth
  • 10.3 Single C19 PCR
    • 10.3.1 Table Single C19 PCR - by Country
    • 10.3.2 Chart - Single C19 PCR Growth
  • 10.4 Single C19 PCR
    • 10.4.1 Table Single C19 PCR - by Country
    • 10.4.2 Chart - Single C19 PCR Growth

11 Global PCR Markets - By Product

  • 11.1 PCR Instruments
    • 11.1.1 Table PCR Instruments - by Country
    • 11.1.2 Chart - PCR Instruments Growth
  • 11.2 PCR Nucleic Acid Extraction
    • 11.2.1 Table PCR Nucleic Acid Extraction - by Country
    • 11.2.2 Chart - PCR Nucleic Acid Extraction Growth
  • 11.3 PCR Consumables
    • 11.3.1 Table PCR Consumables - by Country
    • 11.3.2 Chart - PCR Consumables Growth
  • 11.4 PCR Services
    • 11.4.1 Table Services - by Country
    • 11.4.2 Chart - PCR Services Growth

12 Global PCR Markets - By Place

  • 12.1 PCR Clinical Laboratory
    • 12.1.1 Table PCR Clinical Clinical Laboratory - by Country
    • 12.1.2 Chart - PCR Clinical Clinical Laboratory Growth
  • 12.2 PCR Point of Care
    • 12.2.1 Table PCR Point of Care - by Country
    • 12.2.2 Chart - PCR Point of Care Growth
  • 12.3 PCR Commercial
    • 12.3.1 Table PCR Commercial - by Country
    • 12.3.2 Chart - PCR Commercial Growth
  • 12.4 PCR Pharmaceutical
    • 12.4.1 Table PCR Pharmaceutical - by Country
    • 12.4.2 Chart - PCR Pharmaceutical Growth
  • 12.5 PCR Other Place
    • 12.5.1 Table PCR Other Place - by Country
    • 12.5.2 Chart - PCR Other Place Growth

13 Appendices

  • 13.1 I. United States Medicare System: 2021 Clinical Laboratory Fees Schedule

Table of Tables

  • Table 1 Lab Spending 2014 to 2024
  • Table 2 Market Players by Type
  • Table 3 Five Factors Driving Growth
  • Table 4 Three Factors Limiting Growth
  • Table 5 Market Size by Country
  • Table 6 Global Market by Application
  • Table 7 Global Market by Technology
  • Table 8 Global Market by Product
  • Table 9 Global Market by Place
  • Table 10 PCR Clinical Multiplex by Country
  • Table 11 PCR Clinical Singleplex by Country
  • Table 12 PCR Research by Country
  • Table 13 PCR Single C19 by Country
  • Table 14 PCR Other by Country
  • Table 15 qPCR by Country
  • Table 16 Single C19 PCR by Country
  • Table 17 Single C19 PCR by Country
  • Table 18 PCR Instruments by Country
  • Table 19 PCR Nucleic Acid Extraction by Country
  • Table 20 PCR Consumables by Country
  • Table 21 PCR Services by Country
  • Table 22 PCR Clinical Clinical Laboratory by Country
  • Table 23 PCR Point of Care by Country
  • Table 24 PCR Commercial by Country
  • Table 25 PCR Pharmaceutical by Country
  • Table 26 PCR Other Place by Country
  • Table 27 2021 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 Clinical Lab Spending 2014 to 2024
  • Figure 2 The PCR Process
  • Figure 3 Creation of Sample Droplets for Digital PCR
  • Figure 4 Comparing Syndromic and Targeted Testing
  • Figure 5 Comparing The New Diagnostics and Traditional Testing
  • Figure 6 Growth rates of PCR Diagnostic Segments
  • Figure 7 Base year Global Market Share Chart
  • Figure 8 PCR Market by Application - Segments Growth
  • Figure 9 PCR Market by Application - Base vs. final
  • Figure 10 PCR Market Base year
  • Figure 11 PCR Market Final Year
  • Figure 12 Application Share by Year
  • Figure 13 PCR Market by Technology - Segments Growth
  • Figure 14 PCR Market by Technology - Base vs. final
  • Figure 15 PCR Market by Technology Base year
  • Figure 16 PCR Market by Technology Final Year
  • Figure 17 Technology Share by Year
  • Figure 18 PCR Market by Product - Segments Growth
  • Figure 19 PCR Market by Product - Base vs. final
  • Figure 20 PCR Market by Product Base year
  • Figure 21 PCR Market by Product Final Year
  • Figure 22 Product Share by Year
  • Figure 23 PCR Market by Place - Segments Growth
  • Figure 24 PCR Market by Place - Base vs. final
  • Figure 25 PCR Market by Place Base year
  • Figure 26 PCR Market by Place Final Year
  • Figure 27 Place Share by Year
  • Figure 28 PCR Clinical Multiplex Testing Growth
  • Figure 29 PCR Clinical Singleplex Testing Growth
  • Figure 30 PCR Research Growth
  • Figure 31 PCR Single C19 Growth
  • Figure 32 PCR Other Growth
  • Figure 33 qPCR Growth
  • Figure 34 dPCR Growth
  • Figure 35 Single C19 PCR Growth
  • Figure 36 Single C19 PCR Growth
  • Figure 37 PCR Instruments Growth
  • Figure 38 PCR Nucleic Acid Extraction Growth
  • Figure 39 PCR Consumables Growth
  • Figure 40 PCR Services Growth
  • Figure 41 PCR Clinical Clinical Laboratory Growth
  • Figure 42 PCR Point of Care Growth
  • Figure 43 PCR Commercial Growth
  • Figure 44 PCR Pharmaceutical Growth
  • Figure 45 PCR Other Place Growth